OBJECTIVE: To describe obstetric intervention for extremely preterm births in ten European regions and assess its impact on mortality and short term morbidity. DESIGN: Prospective observational cohort study. SETTING: Ten regions from nine countries participating in the 'Models of Organising Access to Intensive Care for Very Preterm Babies in Europe' (MOSAIC) project. POPULATION: All births from 22 to 29 weeks of gestation (n = 4146) in 2003, excluding terminations of pregnancy. METHODS: Comparison of three obstetric interventions (antenatal corticosteroids, antenatal transfer and caesarean section for fetal indication) rates at 22-23, 24-25 and 26-27 weeks to that at 28-29 weeks and the association of the level of intervention with pregnancy outcome. MAIN OUTCOME MEASURES: Use of antenatal corticosteroids, antenatal transfer and caesarean section by two-week gestational age groups as well as a composite score of these three interventions. Outcomes included stillbirth, in-hospital mortality and intraventricular haemorrhage (IVH) grades III and IV and/or periventricular leucomalacia (PVL) and bronchopulmonary dysplasia (BPD). RESULTS: There were large differences between regions in interventions for births at 22-23 and 24-25 weeks. Differences were most pronounced at 24-25 weeks; in some regions these babies received the same care as babies of 28-29 weeks, whereas elsewhere levels of intervention were distinctly lower. Before 26 weeks and especially at 24-25 weeks, there was an association between the composite intervention score and mortality. No association was observed at 26-27 weeks. For survivors at 24-25 weeks, the intervention score was associated with higher rates of BPD, but not with IVH or PVL. CONCLUSIONS: There are large differences between European regions in obstetric practices at the lower limit of viability and these are related to outcome, especially at 24-25 weeks.
OBJECTIVE: To describe obstetric intervention for extremely preterm births in ten European regions and assess its impact on mortality and short term morbidity. DESIGN: Prospective observational cohort study. SETTING: Ten regions from nine countries participating in the 'Models of Organising Access to Intensive Care for Very Preterm Babies in Europe' (MOSAIC) project. POPULATION: All births from 22 to 29 weeks of gestation (n = 4146) in 2003, excluding terminations of pregnancy. METHODS: Comparison of three obstetric interventions (antenatal corticosteroids, antenatal transfer and caesarean section for fetal indication) rates at 22-23, 24-25 and 26-27 weeks to that at 28-29 weeks and the association of the level of intervention with pregnancy outcome. MAIN OUTCOME MEASURES: Use of antenatal corticosteroids, antenatal transfer and caesarean section by two-week gestational age groups as well as a composite score of these three interventions. Outcomes included stillbirth, in-hospital mortality and intraventricular haemorrhage (IVH) grades III and IV and/or periventricular leucomalacia (PVL) and bronchopulmonary dysplasia (BPD). RESULTS: There were large differences between regions in interventions for births at 22-23 and 24-25 weeks. Differences were most pronounced at 24-25 weeks; in some regions these babies received the same care as babies of 28-29 weeks, whereas elsewhere levels of intervention were distinctly lower. Before 26 weeks and especially at 24-25 weeks, there was an association between the composite intervention score and mortality. No association was observed at 26-27 weeks. For survivors at 24-25 weeks, the intervention score was associated with higher rates of BPD, but not with IVH or PVL. CONCLUSIONS: There are large differences between European regions in obstetric practices at the lower limit of viability and these are related to outcome, especially at 24-25 weeks.
Authors: Waldemar A Carlo; Scott A McDonald; Avroy A Fanaroff; Betty R Vohr; Barbara J Stoll; Richard A Ehrenkranz; William W Andrews; Dennis Wallace; Abhik Das; Edward F Bell; Michele C Walsh; Abbot R Laptook; Seetha Shankaran; Brenda B Poindexter; Ellen C Hale; Nancy S Newman; Alexis S Davis; Kurt Schibler; Kathleen A Kennedy; Pablo J Sánchez; Krisa P Van Meurs; Ronald N Goldberg; Kristi L Watterberg; Roger G Faix; Ivan D Frantz; Rosemary D Higgins Journal: JAMA Date: 2011-12-07 Impact factor: 56.272
Authors: P Brian Smith; Namasivayam Ambalavanan; Lei Li; C Michael Cotten; Matthew Laughon; Michele C Walsh; Abhik Das; Edward F Bell; Waldemar A Carlo; Barbara J Stoll; Seetha Shankaran; Abbot R Laptook; Rosemary D Higgins; Ronald N Goldberg Journal: Pediatrics Date: 2012-05-28 Impact factor: 7.124
Authors: Ashna D Mohangoo; Simone E Buitendijk; Katarzyna Szamotulska; Jim Chalmers; Lorentz M Irgens; Francisco Bolumar; Jan G Nijhuis; Jennifer Zeitlin Journal: PLoS One Date: 2011-11-16 Impact factor: 3.240
Authors: Fredrik Serenius; Gunnar Sjörs; Mats Blennow; Vineta Fellman; Gerd Holmström; Karel Maršál; Eva Lindberg; Elisabeth Olhager; Lennart Stigson; Magnus Westgren; Karin Källen Journal: Acta Paediatr Date: 2013-10-30 Impact factor: 2.299
Authors: Ashna D Mohangoo; Béatrice Blondel; Mika Gissler; Petr Velebil; Alison Macfarlane; Jennifer Zeitlin Journal: PLoS One Date: 2013-05-20 Impact factor: 3.240
Authors: Marie Delnord; Béatrice Blondel; Nicolas Drewniak; Kari Klungsøyr; Francisco Bolumar; Ashna Mohangoo; Mika Gissler; Katarzyna Szamotulska; Nicholas Lack; Jan Nijhuis; Petr Velebil; Luule Sakkeus; James Chalmers; Jennifer Zeitlin Journal: BMC Pregnancy Childbirth Date: 2014-09-13 Impact factor: 3.007
Authors: Rosa Geurtzen; Jos Draaisma; Rosella Hermens; Hubertina Scheepers; Mallory Woiski; Arno van Heijst; Marije Hogeveen Journal: Eur J Pediatr Date: 2016-06-01 Impact factor: 3.183